Advanced search
Publication Cover
Growth Factors Volume 30, 2012 - Issue 5
Submit an article Journal homepage
258
Views
4
CrossRef citations to date
0
Altmetric
Articles

A high-affinity ErbB4Fc fusion protein is a potent antagonist of heregulin-mediated receptor activation

Eva J. Koziolek
,
Jacqueline F. DonoghueOncogenic Signalling Laboratory, Monash Institute for Medical Research, Monash University, Clayton, VIC 3168, Australia
,
John D. BentleyCSIRO Division of Materials Science and Engineering, 343 Royal Parade, Parkville, VIC 3052, Australia
,
George LovreczCSIRO Division of Materials Science and Engineering, 343 Royal Parade, Parkville, VIC 3052, Australia
,
Olan DolezalCSIRO Division of Materials Science and Engineering, 343 Royal Parade, Parkville, VIC 3052, Australia
,
Colin W. WardCSIRO Division of Materials Science and Engineering, 343 Royal Parade, Parkville, VIC 3052, Australia
,
Julie RothackerLudwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Royal Melbourne Hospital, P.O. Box 2008, Parkville, VIC 3050, Australia
,
Edouard C. NiceLudwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Royal Melbourne Hospital, P.O. Box 2008, Parkville, VIC 3050, Australia
,
Antony W. BurgessLudwig Institute for Cancer Research, Melbourne Tumour Biology Branch, Royal Melbourne Hospital, P.O. Box 2008, Parkville, VIC 3050, Australia
,
M. Hafner
,
Terrance G. JohnsOncogenic Signalling Laboratory, Monash Institute for Medical Research, Monash University, Clayton, VIC 3168, Australia
&
Timothy E. AdamsCSIRO Division of Materials Science and Engineering, 343 Royal Parade, Parkville, VIC 3052, AustraliaCorrespondence[email protected]
 show all
Pages 310-319 | Received 21 Jun 2011, Accepted 03 Jul 2012, Published online: 02 Aug 2012

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (4)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.